Thomas M Link1, Galateia Kazakia2. 1. Department of Radiology, University of California, 400 Parnassus Ave, A-367, San Francisco, CA, 94143, USA. Thomas.Link@ucsf.edu. 2. Department of Radiology, University of California, 400 Parnassus Ave, A-367, San Francisco, CA, 94143, USA.
Abstract
PURPOSE OF REVIEW: Patients with inflammatory arthropathies have a high rate of fragility fractures. Diagnostic assessment and monitoring of bone density and quality are therefore critically important. Here, we review standard and advanced techniques to measure bone density and quality, specifically focusing on patients with inflammatory arthropathies. RECENT FINDINGS: Current standard procedures are dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT). DXA-based newer methods include trabecular bone score (TBS) and vertebral fracture assessment (VFA). More advanced imaging methods to measure bone quality include high-resolution peripheral quantitative computed tomography (HR-pQCT) as well as multi-detector CT (MD-CT) and magnetic resonance imaging (MRI). Quantitative ultrasound has shown promise but is not standard to assess bone fragility. While there are limitations, DXA remains the standard technique to measure density in patients with rheumatological disorders. Newer modalities to measure bone quality may allow better characterization of bone fragility but currently are not standard of care procedures.
PURPOSE OF REVIEW: Patients with inflammatory arthropathies have a high rate of fragility fractures. Diagnostic assessment and monitoring of bone density and quality are therefore critically important. Here, we review standard and advanced techniques to measure bone density and quality, specifically focusing on patients with inflammatory arthropathies. RECENT FINDINGS: Current standard procedures are dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT). DXA-based newer methods include trabecular bone score (TBS) and vertebral fracture assessment (VFA). More advanced imaging methods to measure bone quality include high-resolution peripheral quantitative computed tomography (HR-pQCT) as well as multi-detector CT (MD-CT) and magnetic resonance imaging (MRI). Quantitative ultrasound has shown promise but is not standard to assess bone fragility. While there are limitations, DXA remains the standard technique to measure density in patients with rheumatological disorders. Newer modalities to measure bone quality may allow better characterization of bone fragility but currently are not standard of care procedures.
Entities:
Keywords:
Bone fragility; Bone mineral density; Bone quality; DXA; Inflammatory arthropathies; Osteoporosis
Authors: Sanford Baim; Neil Binkley; John P Bilezikian; David L Kendler; Didier B Hans; E Michael Lewiecki; Stuart Silverman Journal: J Clin Densitom Date: 2008 Jan-Mar Impact factor: 2.617
Authors: Angela M Cheung; Malachi J McKenna; Denise M van de Laarschot; M Carola Zillikens; Valerie Peck; Jeevitha Srighanthan; E Michael Lewiecki Journal: J Clin Densitom Date: 2019-07-10 Impact factor: 2.617
Authors: L Vranken; C E Wyers; B van Rietbergen; J H M Driessen; P P M M Geusens; H M J Janzing; R Y van der Velde; J P W van den Bergh Journal: Osteoporos Int Date: 2019-07-17 Impact factor: 4.507
Authors: Karen Rosendahl; Anette Lundestad; John Asle Bjørlykke; Regina Küfner Lein; Oskar Angenete; Thomas Angell Augdal; Lil-Sofie Ording Müller; Diego Jaramillo Journal: PLoS One Date: 2020-11-02 Impact factor: 3.240
Authors: F T Gassert; A Kufner; F G Gassert; Y Leonhardt; S Kronthaler; B J Schwaiger; C Boehm; M R Makowski; J S Kirschke; T Baum; D C Karampinos; A S Gersing Journal: Osteoporos Int Date: 2021-09-18 Impact factor: 4.507
Authors: Tobias Greve; Nithin Manohar Rayudu; Michael Dieckmeyer; Christof Boehm; Stefan Ruschke; Egon Burian; Christopher Kloth; Jan S Kirschke; Dimitrios C Karampinos; Thomas Baum; Karupppasamy Subburaj; Nico Sollmann Journal: Front Endocrinol (Lausanne) Date: 2022-07-11 Impact factor: 6.055
Authors: Nico Sollmann; Edoardo A Becherucci; Christof Boehm; Malek El Husseini; Stefan Ruschke; Egon Burian; Jan S Kirschke; Thomas M Link; Karupppasamy Subburaj; Dimitrios C Karampinos; Roland Krug; Thomas Baum; Michael Dieckmeyer Journal: Front Endocrinol (Lausanne) Date: 2022-01-04 Impact factor: 5.555